ESTEVE to acquire TerSera Therapeutics' Infusion Specialty Therapies Business Unit, Expanding U.S. presence
PR Newswire —
BARCELONA, Spain and DEERFIELD, Ill., Jan. 13, 2026 /PRNewswire/ -- ESTEVE and TerSera Therapeutics LLC announced today that they have entered into an agreement in which ESTEVE will acquire TerSera's Infusion Specialty Therapies Business Unit (IST). This strategic acquisition enables...